Predictive Oncology Inc. (POAI)
NASDAQ: POAI
· Real-Time Price · USD
0.86
-0.01 (-1.15%)
At close: Aug 15, 2025, 3:59 PM
0.86
0.48%
After-hours: Aug 15, 2025, 07:53 PM EDT
Predictive Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.68K | 110.31K | 611.59K | 345.69K | 278.72K | 419.65K | 335.03K | 676.63K | 490.11K | 239.9K | 363.47K | 455.83K | 371.59K | 314.57K | 476.49K | 313.66K | 350.21K | 280.32K |
Cost of Revenue | n/a | 45.12K | 290.63K | 196.92K | 317.13K | 349.98K | 406.3K | 97.87K | 159.76K | 120.14K | 153.44K | 108.15K | 134.07K | 109.44K | 136.22K | 110.17K | 142.88K | 97.76K |
Gross Profit | -15.54K | 65.19K | 320.96K | 148.77K | -38.41K | 69.67K | -71.26K | 578.76K | 330.35K | 119.76K | 210.03K | 347.68K | 237.52K | 205.13K | 340.27K | 203.5K | 207.33K | 182.56K |
Operating Income | -1.98M | -2.29M | -2.12M | -2.31M | -3.19M | -4.24M | -3.51M | -2.74M | -3.96M | -3.46M | -4.43M | -4.13M | 3.84M | -3.41M | -8.56M | -5.49M | -2.6M | -3.78M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47.84K | 28.55K | 42.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | n/a | -2.29M | -2.1M | -2.28M | -3.18M | -4.22M | -3.48M | -2.75M | -3.92M | -3.42M | -7.92M | -4.06M | -10.39M | -3.37M | -8.42M | -5.44M | -2.57M | -3.89M |
Net Income | n/a | -2.44M | -2.17M | -3.09M | -3.18M | -4.22M | -3.48M | -3.16M | -3.92M | -4.26M | -22.26M | -3.99M | -17.49M | -3.33M | -7.76M | -5.44M | -2.57M | -3.89M |
Selling & General & Admin | 2.14M | 1.83M | 1.78M | 1.83M | 2.42M | 2.85M | 3.06M | 3.32M | 3.13M | 2.71M | 3.5M | 3.62M | 2.62M | 2.73M | 3.85M | 2.23M | 2.24M | 3.39M |
Research & Development | 499.71K | 520.41K | 25.99K | n/a | n/a | n/a | 33.46K | 20.67K | 29.37K | 38.8K | 203.56K | 15.15K | 33.39K | 68.22K | 81.49K | 91.03K | 49.69K | 93.63K |
Other Expenses | n/a | n/a | 636.12K | 633.42K | 893.39K | 1.45M | 338.59K | -20.67K | 28.55K | 878.52K | 1.14M | 857.13K | 909.11K | 891.07K | 44.99K | 51.42K | 55.2K | -206.71K |
Operating Expenses | 2.64M | 2.35M | 2.44M | 2.46M | 3.31M | 4.31M | 3.43M | 3.32M | 4.13M | 3.58M | 4.64M | 4.48M | 3.53M | 3.62M | 4.76M | 2.88M | 2.81M | 3.96M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 835.34K | n/a | n/a | 7.14M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 268.96K | 3.63K | 197.39K | 246.65K | 284.42K | 739.73K | 375.48K | 334.44K | 429.1K | 370.24K | 450.04K | 333.38K | 271.02K | 304.47K | 327.23K | 172.87K | 159.79K | 114.64K |
Cost & Expenses | n/a | 2.4M | 2.74M | 2.66M | 3.47M | 4.66M | 3.84M | 3.42M | 4.29M | 3.7M | 4.79M | 4.59M | 3.67M | 3.73M | 4.89M | 2.99M | 2.95M | 4.06M |
Income Tax Expense | n/a | n/a | -5 | n/a | n/a | n/a | n/a | n/a | 155.6K | 835.34K | 14.34M | -71.27K | 7.1M | -43.35K | -661.66K | 2.81M | n/a | n/a |
Shares Outstanding (Basic) | 9.11M | 7.15M | 5.45M | 8.67M | 4.66M | 4.06M | 4.06M | 4.64M | 4M | 3.97M | 3.94M | 3.9M | 3.59M | 3.29M | 3.2M | 3.27M | 2.57M | 1.77M |
Shares Outstanding (Diluted) | 9.11M | 7.15M | 5.45M | 6.4M | 4.66M | 4.06M | 4.06M | 4.03M | 4M | 3.97M | 3.94M | 3.92M | 3.59M | 3.29M | 3.28M | 3.27M | 2.58M | 1.83M |
EPS (Basic) | -0.23 | -0.34 | -0.4 | -0.36 | -0.68 | -1.04 | -0.86 | -0.68 | -0.98 | -0.86 | -2.01 | -1.04 | -2.89 | -1.02 | -2.36 | -1.66 | -1 | -2.13 |
EPS (Diluted) | -0.23 | -0.34 | -0.4 | -0.48 | -0.68 | -1.04 | -0.86 | -0.78 | -0.98 | -0.86 | -2.01 | -1.04 | -2.89 | -1.02 | -2.42 | -1.66 | -1 | -2.2 |
EBITDA | -1.98M | -2.12M | -1.55M | -2.31M | -3.03M | -4.07M | -3.35M | -2.99M | -3.62M | -3.23M | -4.1M | -3.8M | -2.97M | -3.09M | -4.05M | -2.36M | -2.25M | -3.46M |
EBIT | n/a | -2.29M | -2.12M | -2.31M | -3.19M | -4.24M | -3.51M | -2.75M | -3.8M | -3.46M | -4.43M | -4.13M | -3.29M | -3.41M | -4.42M | -2.68M | -2.6M | -3.78M |
Depreciation & Amortization | n/a | 166.07K | 573.64K | 39.8K | 164.16K | 162.56K | 158.34K | 162.99K | 180.13K | 237.85K | 332.69K | 330.94K | 325.84K | 323.6K | 369.81K | 321.36K | 327.15K | 321.98K |